Oric Pharmaceuticals, Inc. (ORIC) stock
ORICNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.00+0.48 (+6.38%)
Close on Nov 17, 2026Market cap $829.22MP/E –Yield –
Oric Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oric Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$111.64M. For fiscal 2025 it was -$110.97M. The highest annual figure on record is -$20.68M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$110.97M | – |
| FY2024 | Dec 31, 2024 | -$112.66M | – |
| FY2023 | Dec 31, 2023 | -$85.69M | – |
| FY2022 | Dec 31, 2022 | -$75.14M | – |
| FY2021 | Dec 31, 2021 | -$59.54M | – |
| FY2020 | Dec 31, 2020 | -$45.27M | – |
| FY2019 | Dec 31, 2019 | -$23.53M | – |
| FY2018 | Dec 31, 2018 | -$20.68M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.61M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.44M | – |
| Q4 FY2025 | Dec 31, 2025 | -$22.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$25.11M | – |
| Q2 FY2025 | Jun 30, 2025 | -$30.84M | – |
| Q1 FY2025 | Mar 31, 2025 | -$32.53M | – |
| Q4 FY2024 | Dec 31, 2024 | -$28.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$28.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$25.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$30.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.65M | – |
| Q2 FY2023 | Jun 30, 2023 | -$21.15M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.63M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.33M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.78M | – |
| Q1 FY2022 | Mar 31, 2022 | -$22.72M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.21M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.90M | – |
| Q4 FY2020 | Dec 31, 2020 | -$17.83M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.58M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$7.15M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.49M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.53M | – |
See a number that looks wrong?